Production (Stage)
Dr. Reddy's Laboratories Limited
RDY
$15.80
-$0.37-2.29%
NYSE
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 14.14% | 13.21% | 10.91% | 8.45% | 10.32% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 14.14% | 13.21% | 10.91% | 8.45% | 10.32% |
| Cost of Revenue | 14.37% | 10.41% | 8.70% | 7.14% | 5.22% |
| Gross Profit | 13.98% | 15.22% | 12.48% | 9.38% | 14.24% |
| SG&A Expenses | 19.49% | 18.87% | 17.29% | 14.48% | 9.79% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -18.99% | -0.95% | -16.74% | -3.87% | -51.65% |
| Total Operating Expenses | 16.47% | 15.03% | 13.27% | 10.89% | 7.42% |
| Operating Income | 6.64% | 7.34% | 3.54% | 1.01% | 20.84% |
| Income Before Tax | 4.57% | 3.88% | 6.15% | 10.45% | 15.45% |
| Income Tax Expenses | 18.32% | 6.80% | 9.28% | -3.80% | 2.82% |
| Earnings from Continuing Operations | 0.57% | 2.93% | 5.15% | 15.58% | 19.73% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -0.68% | 1.48% | 3.48% | 15.58% | 19.73% |
| EBIT | 6.64% | 7.34% | 3.54% | 1.01% | 20.84% |
| EBITDA | 7.75% | 7.91% | 4.24% | 2.67% | 19.39% |
| EPS Basic | -0.80% | 1.32% | 3.25% | 15.15% | 19.32% |
| Normalized Basic EPS | 5.32% | 5.31% | 4.86% | 5.79% | 21.29% |
| EPS Diluted | -0.77% | 1.36% | 3.33% | 15.37% | 19.51% |
| Normalized Diluted EPS | 5.36% | 5.32% | 4.88% | 5.96% | 21.50% |
| Average Basic Shares Outstanding | 0.12% | 0.16% | 0.21% | 0.37% | 0.35% |
| Average Diluted Shares Outstanding | 0.08% | 0.13% | 0.16% | 0.19% | 0.18% |
| Dividend Per Share | -4.05% | -1.03% | -1.03% | -1.03% | -1.03% |
| Payout Ratio | 0.00% | -0.03% | -0.04% | 0.11% | 0.08% |